Vazyme's controlling shareholder, Nanjing Vazyme Investment Management Co., Ltd., increased its stake by 3.26 million shares through centralized competitive trading between June 22 and July 23, 2026, representing approximately 0.63% of the company's total share capital. Following the equity change, the combined shareholding of the controlling shareholder and its concert parties rose from 58.38% to 59.01%. In the first quarter of 2026, the company achieved revenue of 321 million yuan and a net profit attributable to the parent company of 4.18 million yuan.
Nanjing Vazyme Biotech Co LtdControlling shareholder increased stake, signaling confidence and potentially supporting share price.